Lisa A. Hayes
Geen lopende functies
Loopbaan van Lisa A. Hayes
Eerdere bekende functies van Lisa A. Hayes
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Investor Relations Contact | 01-02-2021 | 01-02-2023 |
| Public Communications Contact | 01-02-2021 | 01-02-2023 | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| PROQR THERAPEUTICS N.V. | Investor Relations Contact | 13-12-2018 | - |
| Public Communications Contact | 13-12-2018 | - | |
| CELGENE | Public Communications Contact | - | - |
Opleiding van Lisa A. Hayes
| St. Joseph's University | Masters Business Admin |
| New York University | Graduate Degree |
| Seton Hall University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Nederland | 2 |
Operationeel
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Beurs
- Insiders
- Lisa A. Hayes
- Ervaring
